Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K
T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

86.1K
Overview
86.1K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

18.0K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
18.0K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.7K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bimodality in pan-cancer proteomics reveals new opportunities for biomarker discovery.

Genome biology·2026
Same author

Multimodal Human Scalp Atlas Defines Cell Landscape and Lineage Architecture In Situ.

bioRxiv : the preprint server for biology·2026
Same author

Effectiveness and design specifications of home-based lower extremity rehabilitation systems for patients with stroke: a systematic review and meta-analysis protocol.

BMJ open·2026
Same author

Choroidal and Retinal Imaging Findings in Childhood-Onset Mevalonate Kinase Deficiency: An OCT-Based Case-Control Study.

Ocular immunology and inflammation·2026
Same author

Development of a Healthy Aging Index and analysis of healthy aging trajectories over a 6-year period using the Korean Frailty and Aging Cohort Study.

The Gerontologist·2026
Same author

A pathogenic CD4 T cell phenotype in experimental uveitis shares common features with other immune mediated inflammatory diseases.

Discovery immunology·2026

Related Experiment Video

Updated: Mar 27, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.3K

The Immunopathogenesis of uveitis.

Jimin Han1, James Harper1, David A Copland1,2

  • 1Academic Unit of Ophthalmology, Translational Health Sciences, Bristol, United Kingdom.

Frontiers in Medicine
|March 25, 2026
PubMed
Summary

Uveitis, a major cause of vision loss, involves complex immune responses in the eye. Understanding these pathways, from autoimmune to infectious triggers, guides targeted therapies for better outcomes.

Keywords:
HLA–ERAP axisautoimmunityimmune privilegeinflammasomemolecular mimicryuveitis

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.3K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

3.0K

Related Experiment Videos

Last Updated: Mar 27, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.3K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.3K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

3.0K

Area of Science:

  • Ophthalmology and Immunology
  • Ocular Inflammation and Immune Privilege
  • Immunopathogenesis of Uveitis

Background:

  • Uveitis is a leading cause of preventable blindness, stemming from immune system dysregulation within the eye.
  • Ocular immune privilege is maintained by physical barriers, local immunosuppression, and systemic tolerance mechanisms.
  • Failure of these regulatory mechanisms can lead to various forms of uveitis, including autoimmune, autoinflammatory, infectious, and paraneoplastic.

Purpose of the Study:

  • To elucidate the complex immunopathogenesis of uveitis, encompassing autoimmune, autoinflammatory, infectious, and paraneoplastic etiologies.
  • To highlight the role of genetic susceptibility, T-cell responses, B-cell involvement, and innate pathways in uveitis development.
  • To correlate mechanistic understanding with therapeutic strategies for different uveitis subtypes.

Main Methods:

  • Review of existing literature and animal models (e.g., experimental autoimmune uveitis) to define ocular immune regulation and disease pathways.
  • Analysis of genetic factors (HLA, ERAP), cellular players (T-cells, B-cells, microglia, macrophages), and molecular mediators (cytokines, inflammasomes).
  • Extrapolation of findings from experimental models to human uveitis pathogenesis and therapeutic approaches.

Main Results:

  • Autoimmune uveitis involves genetic predisposition, T-cell activation (Th1/Th17), and inflammatory cascades amplified by myeloid cells.
  • Infectious and post-infectious uveitis result from direct infection or immune responses mimicking pathogens.
  • Autoinflammatory uveitis is driven by innate immune pathway dysregulation (inflammasome/IL-1), while paraneoplastic uveitis involves anti-tumor immunity cross-reactivity.
  • Tissue-resident memory T-cells may contribute to uveitis relapse.

Conclusions:

  • Therapeutic strategies for uveitis must be tailored to the underlying immunopathology, targeting specific immune pathways.
  • Antimicrobials are crucial for infectious uveitis, followed by anti-inflammatory treatment.
  • Steroid-sparing agents targeting TNF and IL-6, or IL-1 blockade, are effective for autoimmune and autoinflammatory uveitis, respectively.
  • Advances in humanized modeling are essential for refining condition-specific treatments.